Efficacy and mechanism of action of cipargamin as an antibabesial drug candidate
H. Li, S. Ji, N. R. Ariefta, E. M. S. Galon, S. A. El-Sayed, T. Do, L. Jia, M. Sakaguchi, M. Asada, Y. Nishikawa, X. Qin, M. Liu, X. Xuan
This study evaluates cipargamin's efficacy against Babesia species and identifies resistance mechanisms, showing its effectiveness as an anti-babesial drug but limitations due to resistance, with combination therapy with tafenoquine offering potential.
bioRxiv · Jul 15, 2024Microbiology